                         SEQUENCE LISTING

<110>  Baylor Research Institute
       Banchereau, Jacques F.
       Klechevsky, Eynav
       Zurawski, Gerard
       Zurawski, Sandra
 
<120>  DENDRITIC CELL IMMUNORECEPTORS (DCIR)-MEDIATED CROSSPRIMING OF 
       HUMAN CD8+ T CELLS

<130>  BHCS:2452

<140>  Concurrently Herewith.
<141>  2011-05-04

<150>  61/332,465
<151>  2010-05-07

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide.

<400>  1

Gly Ile Leu Gly Phe Val Phe Thr Leu 
1               5                   


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide.

<400>  2

Glu Leu Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide.

<400>  3

Thr Leu Asn Ala Trp Val Lys Val Val 
1               5                   


<210>  4
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  4
ggatggtggg aagatggata cagttggtgc agcatc                                 36


<210>  5
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  5
gtcactggct cagggaaata gcccttgacc aggcatc                                37


<210>  6
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  6
gctagctgat taattaa                                                      17


<210>  7
<211>  100
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  7
ctagttgctg gctaatggac cccaaaggct ccctttcctg gagaatactt ctgtttctct       60

ccctggcttt tgagttgtcg tacggattaa ttaagggccc                            100


<210>  8
<211>  61
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide.

<400>  8

Asp Thr Thr Glu Ala Arg His Pro His Pro Pro Val Thr Thr Pro Thr 
1               5                   10                  15      


Thr Asp Arg Lys Gly Thr Thr Ala Glu Glu Leu Ala Gly Ile Gly Ile 
            20                  25                  30          


Leu Thr Val Ile Leu Gly Gly Lys Arg Thr Asn Asn Ser Thr Pro Thr 
        35                  40                  45              


Lys Gly Glu Phe Cys Arg Tyr Pro Ser His Trp Arg Pro 
    50                  55                  60      


<210>  9
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide.

<400>  9

Glu Ala Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide.

<400>  10

Lys Leu Gln Cys Val Asp Leu His Val 
1               5                   


